Nelya (Ethinylestradiol, Gestodene | Lactose)

Ethinylestradiol and Gestodene, the active ingredients in Nelya, are combined oral contraceptives presented as tablets for oral use. They are prescribed to prevent pregnancy by suppressing ovulation and stabilising the endometrium.\nGNH India supplies Nelya as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nelya is a combined oral contraceptive that acts on the hypothalamic‑pituitary‑ovarian axis to prevent pregnancy and manage menstrual disorders.\n- Contraception: Prevents pregnancy by inhibiting ovulation and altering cervical mucus.\n- Menstrual cycle regulation: Provides regular, predictable bleeding patterns for women with irregular cycles.\n- Management of dysmenorrhea: Reduces menstrual pain by stabilising endometrial growth.

Nelya may cause a range of adverse reactions, most of which are mild and transient.\n\nCommon Side Effects:\n- Nausea: mild to moderate stomach upset.\n- Breast tenderness: temporary swelling or discomfort.\n- Headache: occasional mild to moderate pain.\n- Spotting or breakthrough bleeding: irregular light bleeding between periods.\n- Mood changes: mild fluctuations in mood or irritability.\n- Weight gain: modest fluid retention or appetite increase.\n\nSerious or Rare Side Effects:\n- Venous thromboembolism: blood clots in deep veins or lungs.\n- Arterial thrombosis: clot formation in arteries leading to stroke or heart attack.\n- Severe hypertension: sudden, high blood pressure.\n- Liver tumor: benign hepatic adenoma.\n- Allergic reaction: rash, itching, swelling, or anaphylaxis.\n- Severe depression or suicidal thoughts.

Before prescribing Nelya, clinicians should evaluate individual risk factors and counsel patients on safe use.\n- Cardiovascular assessment: review history of thrombosis, hypertension, or smoking.\n- Liver function: check for hepatic disease that may alter hormone metabolism.\n- Drug interaction review: identify concurrent use of enzyme‑inducing agents.\n- Pregnancy testing: ensure patient is not already pregnant before initiation.\n- Breastfeeding guidance: discuss potential effects on lactation.\n- Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Nelya can interact with several medicines that affect hormone metabolism or clotting risk.\n\nMajor Interactions (Avoid):\n- Strong CYP3A4 inducers (e.g., rifampicin, carbamazepine, phenytoin): may markedly reduce contraceptive efficacy.\n- Anticoagulants (e.g., warfarin): combined use may increase thrombotic risk.\n- Selective serotonin reuptake inhibitors (high dose): may heighten risk of serotonin syndrome when used with certain hormonal agents.\n\nModerate Interactions (Monitor Closely):\n- Antibiotics such as tetracycline or metronidazole: may slightly lower effectiveness.\n- Antifungals (e.g., ketoconazole, itraconazole): can increase hormone levels, raising side‑effect potential.\n- Herbal supplements like St. John’s wort: may diminish contraceptive protection.